These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 30686750

  • 1. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
    Samaan F, Carvalho AB, Pillar R, Rocha LA, Cassiolato JL, Cuppari L, Canziani MEF.
    J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
    [Abstract] [Full Text] [Related]

  • 2. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study.
    Delanaye P, Weekers L, Warling X, Moonen M, Smelten N, Médart L, Krzesinski JM, Cavalier E.
    Nephrol Dial Transplant; 2013 Jul; 28(7):1779-86. PubMed ID: 23378417
    [Abstract] [Full Text] [Related]

  • 3. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
    Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT, Tangpricha V.
    Endocr Pract; 2008 Jul; 14(1):10-7. PubMed ID: 18238736
    [Abstract] [Full Text] [Related]

  • 4. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.
    Ramirez-Sandoval JC, Arvizu-Hernandez M, Cruz C, Vazquez-Cantu B, Rojas-Concha LJ, Tamez L, Reynerio F, Gomez FE, Correa-Rotter R.
    J Nephrol; 2019 Aug; 32(4):645-659. PubMed ID: 30888584
    [Abstract] [Full Text] [Related]

  • 5. Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease.
    Yadav AK, Kumar V, Banerjee D, Gupta KL, Jha V.
    J Steroid Biochem Mol Biol; 2018 Jun; 180():15-18. PubMed ID: 29331722
    [Abstract] [Full Text] [Related]

  • 6. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
    Alvarez JA, Law J, Coakley KE, Zughaier SM, Hao L, Shahid Salles K, Wasse H, Gutiérrez OM, Ziegler TR, Tangpricha V.
    Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
    [Abstract] [Full Text] [Related]

  • 7. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.
    Molina P, Górriz JL, Molina MD, Peris A, Beltrán S, Kanter J, Escudero V, Romero R, Pallardó LM.
    Nephrol Dial Transplant; 2014 Jan; 29(1):97-109. PubMed ID: 23975842
    [Abstract] [Full Text] [Related]

  • 8. The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.
    Alshahawey M, El Borolossy R, El Wakeel L, Elsaid T, Sabri NA.
    Nutr Metab Cardiovasc Dis; 2021 Feb 08; 31(2):626-633. PubMed ID: 33594986
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis.
    Wasse H, Huang R, Long Q, Singapuri S, Raggi P, Tangpricha V.
    Am J Clin Nutr; 2012 Feb 08; 95(2):522-8. PubMed ID: 22237061
    [Abstract] [Full Text] [Related]

  • 10. The Effect of Vitamin D Supplementation on Bone Metabolic Markers in Chronic Kidney Disease.
    Yadav AK, Kumar V, Kumar V, Banerjee D, Gupta KL, Jha V.
    J Bone Miner Res; 2018 Mar 08; 33(3):404-409. PubMed ID: 29044707
    [Abstract] [Full Text] [Related]

  • 11. Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.
    Kendrick J, Andrews E, You Z, Moreau K, Nowak KL, Farmer-Bailey H, Seals DR, Chonchol M.
    Clin J Am Soc Nephrol; 2017 Sep 07; 12(9):1438-1446. PubMed ID: 28784657
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D levels, vitamin D supplementation, and prognosis in patients with chronic kidney disease
.
    Namir Y, Cohen MJ, Haviv YS, Slotki I, Shavit L.
    Clin Nephrol; 2016 Oct 07; 86(10):165-74. PubMed ID: 27616756
    [Abstract] [Full Text] [Related]

  • 13. Cholecalciferol supplementation and angiogenic markers in chronic kidney disease.
    Kaur J, Kamboj K, Yadav AK, Kaur P, Kumar V, Jha V.
    PLoS One; 2022 Oct 07; 17(6):e0268946. PubMed ID: 35657784
    [Abstract] [Full Text] [Related]

  • 14. The influence of renal function on vitamin D metabolism in the very elderly.
    Van Pottelbergh G, Matheï C, Vaes B, Adriaensen W, Gruson D, Degryse JM.
    J Nutr Health Aging; 2013 Feb 07; 17(2):107-11. PubMed ID: 23364486
    [Abstract] [Full Text] [Related]

  • 15. Cholecalciferol supplementation in chronic kidney disease: restoration of vitamin D status and impact on parathyroid hormone.
    Garcia-Lopes MG, Pillar R, Kamimura MA, Rocha LA, Canziani ME, Carvalho AB, Cuppari L.
    Ann Nutr Metab; 2012 Feb 07; 61(1):74-82. PubMed ID: 22889840
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease.
    Kim SM, Choi HJ, Lee JP, Kim DK, Oh YK, Kim YS, Lim CS.
    J Ren Nutr; 2014 Jan 07; 24(1):20-5. PubMed ID: 24216258
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D supplementation improves endothelial dysfunction in patients with non-dialysis chronic kidney disease.
    Zhang Q, Zhang M, Wang H, Sun C, Feng Y, Zhu W, Cao D, Shao Q, Li N, Xia Y, Tang T, Wan C, Liu J, Jin B, Zhao M, Jiang C.
    Int Urol Nephrol; 2018 May 07; 50(5):923-927. PubMed ID: 29484540
    [Abstract] [Full Text] [Related]

  • 18. Effect of high-dose cholecalciferol (vitamin D3) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial.
    Rovner AJ, Stallings VA, Rutstein R, Schall JI, Leonard MB, Zemel BS.
    Osteoporos Int; 2017 Jan 07; 28(1):201-209. PubMed ID: 27837268
    [Abstract] [Full Text] [Related]

  • 19. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.
    Bucharles S, Barberato SH, Stinghen AEM, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-Filho R.
    J Ren Nutr; 2012 Mar 07; 22(2):284-291. PubMed ID: 21908203
    [Abstract] [Full Text] [Related]

  • 20. Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol.
    Alshayeb H, Showkat A, Wall BM, Gyamlani GG, David V, Quarles LD.
    J Clin Endocrinol Metab; 2014 Oct 07; 99(10):E1830-7. PubMed ID: 24960544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.